The roundtable discussion will highlight real-world case examples that offer insights into how high-dose, high-RPM therapy is delivering results where it matters most.

This webinar, funded by AstraZeneca, will cover ongoing critical trials of combination locoregional therapy and immunotherapy in the liver.

This micro session webinar provides an in-depth look at the planning process and multidisciplinary approach to image-guided biopsy and surgical management of musculoskeletal (MSK) tumors.

This webinar will cover the role of immunotherapy as a treatment for HCC and in combination with locoregional therapies, as well as looking at mechanisms of resistance, biomarker predictions and other therapeutic targets.

Join us for a 100, 200 level webinar with a focus on the finer details of patient evaluation and procedure techniques of benign bone lesions, demonstrating bone grafting for UBC/ABC. Experts will walk you through diagnosing and treating benign bone lesions, including osteoid osteoma — from its presentation, imaging, and natural history to both ablative and non-ablative treatment approaches. Cases will highlight cone beam CT-guided microwave ablation techniques, bone grafting methods, and management of aneurysmal bone cysts (ABC).

This webinar will cover advances in treatment of hepatocellular carcinoma (HCC) with a shift towards combination therapies and sequencing strategies to optimize patient outcome

This panel discussion will feature leading interventional radiologists sharing their clinical experience with microwave and radiofrequency ablation technologies—specifically Emprint™ Microwave Ablation and OsteoCool™ RF Ablation. The session will highlight treatment strategies, case insights, and procedural considerations across soft tissue and bone tumor applications.

Join us for an intermediate-level (100–200) musculoskeletal (MSK) webinar focused on the interventional treatment of malignant and metastatic bone lesions in both the axial and appendicular skeleton, covering techniques like ablation, cementation, and embolization.

In this 100-200 level webinar, faculty will focus on the evolving role of percutaneous ablation techniques in the management of non-renal tumors, showcasing multi-disciplinary approaches, innovative technologies, and expert insights. Attendees will gain an in-depth understanding of various percutaneous methods for tumor ablation, energy sources, and procedural techniques.

SIO’s 100-200 level Lung focused webinar explores the cutting-edge developments in lung treatment, including the emerging role of Pulse Electric Field (PEF) technology as a non-thermal ablation technique. We will cover the theoretical concepts behind PEF, review current research efforts, and provide a detailed look at its clinical applications in lung treatment.